#johnsonandjohnson
Texas Attorney General moves to block Kenvue’s $ dividend amid Tylenol lawsuit
Texas Attorney General Ken Paxton has filed a motion to block pharmaceutical company Kenvue—the manufacturer of Tylenol—from issuing a scheduled dividend payment later this month. The move comes as the state pursues a high-profile lawsuit against Kenvue and its former parent company, Johnson & Johnson, alleging deceptive marketing practices tied to the use of Tylenol during pregnancy. The dividend, set for distribution on November 26, has become the latest f
Texas Attorney General moves to block Kenvue’s $ dividend amid Tylenol lawsuit
Texas Attorney General Ken Paxton has filed a motion to block pharmaceutical company Kenvue—the manufacturer of Tylenol—from issuing a scheduled dividend payment later this month. The move comes as the state pursues a high-profile lawsuit against Kenvue and its former parent company, Johnson & Johnson, alleging deceptive marketing practices tied to the use of Tylenol during pregnancy. The dividend, set for distribution on November 26, has become the latest f
Kimberly-Clark to acquire Kenvue in $48.7 billion deal, creating consumer health giant
Kimberly-Clark announced plans to acquire Kenvue, the maker of Tylenol and Listerine, in a cash and stock deal valued at approximately $48.7 billion. The transaction marks one of the largest corporate takeovers of the year and will unite some of the world’s most recognized household and healthcare brands under a single company. Following the merger, shareholders of Kimberly-Clark will hold about 54 percent of the combined entity, while Kenvue investors will own the remaining 46 pe
Kimberly-Clark to acquire Kenvue in $48.7 billion deal, creating consumer health giant
Kimberly-Clark announced plans to acquire Kenvue, the maker of Tylenol and Listerine, in a cash and stock deal valued at approximately $48.7 billion. The transaction marks one of the largest corporate takeovers of the year and will unite some of the world’s most recognized household and healthcare brands under a single company. Following the merger, shareholders of Kimberly-Clark will hold about 54 percent of the combined entity, while Kenvue investors will own the remaining 46 pe
Johnson & Johnson faces UK lawsuit over asbestos baby powder cancer claims
American healthcare giant Johnson & Johnson is confronting one of its most serious legal battles in the United Kingdom, as thousands of claimants have filed a collective lawsuit alleging that the company’s talc-based baby powder contained asbestos, a known carcinogen. The case, now moving through UK courts, accuses the multinational of knowingly selling contaminated products for decades while misleading consumers about their safety. According to court filings, the lawsuit invo
Johnson & Johnson faces UK lawsuit over asbestos baby powder cancer claims
American healthcare giant Johnson & Johnson is confronting one of its most serious legal battles in the United Kingdom, as thousands of claimants have filed a collective lawsuit alleging that the company’s talc-based baby powder contained asbestos, a known carcinogen. The case, now moving through UK courts, accuses the multinational of knowingly selling contaminated products for decades while misleading consumers about their safety. According to court filings, the lawsuit invo









